Study for people with dizziness when standing from Parkinson's or nerve failure
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests a new treatment for dizziness and low blood pressure when standing, caused by Parkinson's disease or pure autonomic failure. It may help if you already take medications like midodrine or droxidopa.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 to 85 years old
- You have been diagnosed with Parkinson's disease or pure autonomic failure that causes dizziness when standing
- Your blood pressure drops at least 20 points (top number) or 10 points (bottom number) when you stand up within 3 minutes
- You score 4 or higher on a dizziness assessment question
- You are currently taking or have responded to medications like midodrine or droxidopa for this condition
- You must be able to walk with or without a walker or cane
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks how your body controls breathing and heart rate when you stand up, especially if you get dizzy from low blood pressure. It may help researchers understand what causes symptoms and how to improve testing for people with this condition.
This study follows people over time to better understand “synucleinopathies,” which are conditions that affect the nervous system as it develops and progresses. You may be asked to return for visits and report symptoms, especially those that happen when you stand up.
This trial tests whether breathing in small amounts of carbon dioxide can help people with neurogenic orthostatic hypotension (a condition that causes blood pressure to drop when standing). The goal is to see if this simple treatment can improve symptoms and quality of life.
This proof-of-concept pilot study tests whether a controlled breathing test that re-breathes carbon dioxide can improve symptoms or body responses in people with neurogenic orthostatic hypotension (a drop in blood pressure when standing). It may help researchers understand how the nervous system involved in blood pressure control works.
This early (Phase 1) study tests whether midodrine and droxidopa can improve blood-flow pooling in the belly in people with nerve problems that affect blood pressure when standing. It’s looking at safety and how the body responds, which may help reduce dizziness or fainting for some participants.
This study uses an accelerometer (a wearable motion sensor) to measure symptoms and blood pressure changes when you stand up. It may help doctors better track how neurogenic orthostatic hypotension affects you and how well current treatments are working.
Hear when a new Neurogenic Orthostatic Hypotension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.